Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Bridging minds and policies: supporting early career researchers in translating computational psychiatry research
    Published on 2024-02-27
    3 years ago
  • Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward
    Published on 2024-02-25
    3 years ago
  • Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial
    Published on 2024-02-25
    3 years ago
  • Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets
    Published on 2024-02-23
    3 years ago
  • In memoriam: Kenneth E. Moore
    Published on 2024-02-22
    3 years ago
  • Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach
    Published on 2024-02-22
    3 years ago
  • The sinking platform test: a novel paradigm to measure persistence in animal models
    Published on 2024-02-22
    3 years ago
« Previous 1 … 104 105 106 107 108 … 143 Next »
Journal of Psychopharmacology
  • Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action
    Published on 2021-03-20
    5 years ago
  • Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence
    Published on 2021-03-17
    5 years ago
  • Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials
    Published on 2021-03-15
    6 years ago
  • Methylphenidate reduces orienting bias in healthy individuals
    Published on 2021-03-15
    6 years ago
  • Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement
    Published on 2021-03-11
    6 years ago
  • Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania
    Published on 2021-03-11
    6 years ago
  • Associations between lifetime classic psychedelic use and markers of physical health
    Published on 2021-03-10
    6 years ago
« Previous 1 … 104 105 106 107 108 … 154 Next »
European Neuropsychopharmacology
  • Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility
    Published on 2021-06-09
    5 years ago
  • Autoimmune encephalitis or autoimmune psychosis?
    Published on 2021-06-06
    5 years ago
  • Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects
    Published on 2021-06-05
    5 years ago
  • Emotional cognition subgroups in mood disorders: Associations with familial risk
    Published on 2021-06-05
    5 years ago
  • Polygenic risk scores in psychiatry – Large potential but still limited clinical utility
    Published on 2021-06-04
    5 years ago
  • Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study
    Published on 2021-06-01
    5 years ago
  • Oxytocin blood concentrations in alcohol use disorder: A cross-sectional, longitudinal, and sex-separated study
    Published on 2021-05-31
    5 years ago
« Previous 1 … 104 105 106 107 108 … 170 Next »

   Pharma Pub